Indinavir

Indinavir is an antiretroviral protease inhibitor used in the therapy and prevention of human immunodeficiency virus (HIV) infection and the acquired immunodeficiency syndrome (AIDS). Indinavir can cause transient and usually asymptomatic elevations in serum aminotransferase levels and mild elevations in indirect bilirubin concentration. Indinavir is a rare cause of clinically apparent, acute liver injury. In HBV or HCV coinfected patients, antiretroviral therapy with indinavir may result in an exacerbation of the underlying chronic hepatitis B or C. It is grouped under the following drug class(es): HIV-1 protease inhibitors. Its therapeutic use is listed as anti-infectives and antivirals. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Crixivan and indinavirum. Its PubChem CID is 5362440.

CAS No 150378-17-9
Molecular Formula C36H47N5O4
Molecular Weight 613.8 g/mol
Synonyms (2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-5-[[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino]-5-oxopentyl]-N–tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide

Frequently Asked Questions